SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-582737
Filing Date
2016-05-09
Accepted
2016-05-09 07:16:25
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d176250d10q.htm 10-Q 478246
2 EX-31.1 d176250dex311.htm EX-31.1 9194
3 EX-31.2 d176250dex312.htm EX-31.2 9191
4 EX-32.1 d176250dex321.htm EX-32.1 5406
  Complete submission text file 0001193125-16-582737.txt   2349006

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldx-20160331.xml EX-101.INS 316561
6 XBRL TAXONOMY EXTENSION SCHEMA aldx-20160331.xsd EX-101.SCH 31003
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20160331_cal.xml EX-101.CAL 37714
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20160331_def.xml EX-101.DEF 77058
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20160331_lab.xml EX-101.LAB 258805
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20160331_pre.xml EX-101.PRE 173503
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 161629882
SIC: 2834 Pharmaceutical Preparations